SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : High Growth Techstocks for 1998

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John R. Sashko who wrote (498)4/20/1998 11:10:00 PM
From: Mkilloran  Read Replies (1) of 598
 
John....PFE will do great with Vagara and it's other drugs....
options players will ride the trend higher..

IMO Vivus will survive with a 20% share of the growing ED market with $200+ mill sales in 99...That's small compared to Pfe but nice for a small company.

The more severe ED patients will use Muse and Muse II (now inphase iii trials).

Vivus could be a 4 or 5 banger..IMO

Good luck with Pfe

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext